Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2021-01-18 2020-12-17
Drug Identification Number 02236916 02236916
Brand name ACYCLOVIR SODIUM INJECTION ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection Acyclovir Sodium Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ACYCLOVIR ACYCLOVIR
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 20mL vial 20mL vial
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-01-27 2021-01-15
Actual start date
Estimated end date 2021-02-01 2021-02-01
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments